Daunorubicin: all 110 studies that test it
Page 2 of 2. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- Liposomal Daunorubicin in Treating Patients With Metastatic Breast CancerStatus unknownNCT00004207Phase 1
- Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic LeukemiaCompletedNCT00003783Phase 2
- Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedNCT00003700Phase 2
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic LeukemiaCompletedNCT00003671Phase 2
- Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic SyndromeCompletedNCT00003593Phase 3
- Combination Chemotherapy in Treating Children With Acute Lymphocytic LeukemiaCompletedNCT00002812Phase 3
- Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
- Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00002756Phase 2
- Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedNCT00002704Phase 2
- Combination Chemotherapy in Treating Children With LymphomaCompletedNCT00002590Phase 2